StockData
Lakefront Biotherapeutics NV logo

Lakefront Biotherapeutics NV (LKFT) stock

LKFTNasdaqPharmaceutical PreparationsAlso trades as GLPGF
Financials through fiscal 2025, year ended Dec 31, 2025Score 7/30
$34.39−0.40 (-1.15%)

Close on Nov 17, 2026Market cap $2.27BP/E 6.4Yield –

Lakefront Biotherapeutics total debt

Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.

No total debt figures for Lakefront Biotherapeutics

Lakefront Biotherapeutics has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More Lakefront Biotherapeutics figures

See a number that looks wrong?